Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuenlei Parng

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|February 1, 2005
In vivo zebrafish assays for toxicity testingChuenlei Parng
Hearing Research|July 15, 2005
The use of zebrafish for assessing ototoxic and otoprotective agentsChristopher Ton, Chuenlei Parng
Assay and Drug Development Technologies|April 20, 2004
Zebrafish: a preclinical model for drug screeningChuenlei Parng, Wen Lin Seng, Carlos Semino, et al.
Methods in Cell Biology|December 18, 2004
Zebrafish apoptosis assays for drug discoveryChuenlei Parng, Nate Anderson, Christopher Ton, et al.
Journal of Pharmacological and Toxicological Methods|June 14, 2006
Neurotoxicity assessment using zebrafishChuenlei Parng, Nicole Marie Roy, Christopher Ton, et al.
Neurotoxicology and Teratology|July 4, 2006
A zebrafish assay for identifying neuroprotectants in vivoChuenlei Parng, Christopher Ton, Ying-Xin Lin, et al.
The AAPS Journal|August 31, 2013
A mathematical model of the effect of immunogenicity on therapeutic protein pharmacokineticsXiaoying Chen, Timothy Hickling, Eugenia Kraynov, et al.
The AAPS Journal|November 8, 2018
Approaches to Resolve False Reporting in Neutralizing Antibody Assays Caused by Reagent Leaching from Affinity Capture Elution Solid PhaseYuhong Xiang, John Kamerud, Jean Donley, et al.
The AAPS Journal|April 13, 2019
Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXa<sup>I16L</sup> in Preclinical SpeciesChuenlei Parng, Michael Bolt, Debra D Pittman, et al.
The AAPS Journal|March 31, 2019
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal AntibodyYuhong Xiang, Chuenlei Parng, Katrina Olson, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|February 1, 2005
In vivo zebrafish assays for toxicity testingChuenlei Parng
Hearing Research|July 15, 2005
The use of zebrafish for assessing ototoxic and otoprotective agentsChristopher Ton, Chuenlei Parng
Assay and Drug Development Technologies|April 20, 2004
Zebrafish: a preclinical model for drug screeningChuenlei Parng, Wen Lin Seng, Carlos Semino, et al.
Methods in Cell Biology|December 18, 2004
Zebrafish apoptosis assays for drug discoveryChuenlei Parng, Nate Anderson, Christopher Ton, et al.
Journal of Pharmacological and Toxicological Methods|June 14, 2006
Neurotoxicity assessment using zebrafishChuenlei Parng, Nicole Marie Roy, Christopher Ton, et al.
Neurotoxicology and Teratology|July 4, 2006
A zebrafish assay for identifying neuroprotectants in vivoChuenlei Parng, Christopher Ton, Ying-Xin Lin, et al.
The AAPS Journal|August 31, 2013
A mathematical model of the effect of immunogenicity on therapeutic protein pharmacokineticsXiaoying Chen, Timothy Hickling, Eugenia Kraynov, et al.
The AAPS Journal|November 8, 2018
Approaches to Resolve False Reporting in Neutralizing Antibody Assays Caused by Reagent Leaching from Affinity Capture Elution Solid PhaseYuhong Xiang, John Kamerud, Jean Donley, et al.
The AAPS Journal|April 13, 2019
Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXa<sup>I16L</sup> in Preclinical SpeciesChuenlei Parng, Michael Bolt, Debra D Pittman, et al.
The AAPS Journal|March 31, 2019
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal AntibodyYuhong Xiang, Chuenlei Parng, Katrina Olson, et al.
Pageof 2